Advertisement

Topics

Protherics Company Profile

20:48 EST 19th November 2017 | BioPortfolio

We are a biopharmaceutical business, with approximately 125 employees and operations in the United Kingdom, United States and Australia. We are focused on immunotherapeutic research and development, and were formed in September 1999 through the merger of Proteus International Plc and Therapeutic Antibodies Inc.

Our products are based on two proprietary technology platforms:



Highly purified polyclonal antibodies for acute medical emergency applications. These products are in late stage development or already on the market and include CroFab™, DigiFab™ and CytoTAb® .

Novel peptide-conjugate vaccines to treat chronic diseases. These products are in pre-clinical or clinical development and include GnRH(gonadotropin releasing hormone) and angiotensin vaccines.

Location

The Health Business and Technical Park
Runcorn
Cheshire
W47 4QF
United Kingdom

Contact

Phone: 01928 518 000
Fax: 01928 518 002
Email: barry.riley@protherics.com


News Articles [2 Associated News Articles listed on BioPortfolio]

Recent Deals Discussion: Eli Lilly/Imclone and BTG/Protherics

In this programme Fintan Walton talks to Tibor Papp and Steven Renwick of PharmaVentures Consultancy. They discuss the recent deals between BTG and Protherics and Eli Lilly and ImClone.

SynteractHCR Announces New Chief Medical Officer Dr. Frank Santoro

Dr. Santoro joins growing team of experts at international CRO SynteractHCR, a full-service, international contract research organization (CRO), announces that Dr. Fran...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

A Comparison of Crotalinae (Pit Viper) Equine Immune F(ab)2 Antivenom (Anavip) and Crotalidae Polyvalent Immune Fab, Ovine Antivenom (CroFab) in the Treatment of Pit Viper Envenomation

This phase II study was a prospective, randomized, open-label, multi-center study in the United States, involving patients from 18 to 70 years of age, comparing Anavip (Antivenin Crotalina...

Companies [1 Associated Companies listed on BioPortfolio]

Protherics

We are a biopharmaceutical business, with approximately 125 employees and operations in the United Kingdom, United States and Australia. We are focused on immunotherapeutic research and development, a...

More Information about "Protherics" on BioPortfolio

We have published hundreds of Protherics news stories on BioPortfolio along with dozens of Protherics Clinical Trials and PubMed Articles about Protherics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Protherics Companies in our database. You can also find out about relevant Protherics Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...


Corporate Database Quicklinks



Searches Linking to this Company Record